University of Nottingham
  

Designing treatments for mood and psychotic disorders 

Mike Craven and mental health digital support 3

KTN’s Neurotechnology SIG and MindTech are running a workshop on the treatment of mood and psychotic disorders, with a bio-design approach.

KTN’s Neurotechnology Special Interest Group (Neurotechnology SIG) will be running a Mood and Psychosis Biodesign workshop on 12th Nov, in Nottingham in collaboration with MindTech (NIHR Mental Health MedTech Co-operative).

MindTech is a national centre funded by the National Institute for Health Research (NIHR). It focusses on the area of mental health developing different methods to advance the adoption of these technologies in the NHS. The work is very much a co-partnership with the University of Nottingham and the local Nottinghamshire NHS Trust, based at the Institute of Mental Health in the University of Nottingham Innovation Park. In particular MindTech focusses on many non-drug treatments known as psychosocial interventions. Areas of interest include mood disorders, psychosis, dementia and neurodevelopmental disorders such as Attention Deficit Hyperactivity Disorder (ADHD) and Tourette Syndrome.  

The event will be co-hosted by CHT's Dr. Michael Craven is Senior Research Fellow within the University of Nottingham and works fulltime for MindTech.  

Read more about this event on the KTN website and register here